Summary:

- Researchers at Penn State have found that a simple treatment using a compound called alpha-ketoglutarate (AKG) may help reduce inflammation and its side effects in pregnant women.
- The study showed that AKG supplementation during pregnancy can help regulate the immune system and reduce inflammation, which is important as excessive inflammation can lead to complications like preeclampsia, gestational diabetes, and preterm birth.
- The findings suggest that AKG could be a promising, low-cost intervention to improve maternal and fetal health, and the researchers plan to conduct further studies to explore the potential benefits of this treatment.